Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI filing briefs · archive

8-K filings in May 2023, explained

17 material Form 8-K filings that 16 companies we cover made with the SEC in May 2023, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

1 of 17 briefs matches

newest first · times in ET
SCNIScinai Immunotherapeutics Ltd. May 11, 5:20 PM ET

Scinai: Director George Lowell resigns from board, stays on advisory board

Neutral leadership Written later 5.02

Director George Lowell resigned from the board of directors effective May 12, 2023, after serving since 2008. The filing states he did not resign over any disagreement with the company, and he will remain on the Scientific Advisory Board as a liaison between that board and the Board. The filing names the registrant as BiondVax Pharmaceuticals Ltd.; the company and Mr. Lowell are still negotiating his compensation for the new roles.

  • Mr. Lowell submitted his board resignation on May 10, 2023, effective May 12, 2023
  • He had served as a Board member since 2008; the Board chairman, Mark Germain, thanked him for 15 years of service
  • Mr. Lowell will stay on the Scientific Advisory Board and become a liaison between it and the Board
  • Compensation for his continuing and new roles is still under discussion
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.